Clinical and pathological aspects of toxic myopathies

Peters SA, Kley RA (2019) Toxic and drug-induced myopathies. Clinical scenario and imaging. In: Barkhof F, Jäger HR, Thurnher MM, Rovira A (eds) Clinical neuroradiology - the ESNR textbook. Springer Nature

Google Scholar 

Khefli A, Azzouz M, Abtroun R et al (2016) Myopathies toxiques: vue d’ensemble. Toxicol Analyt Clin 28:187–199

Google Scholar 

Doughty CT, Amato AA (2019) Toxic myopathies. Continuum (Minneap Minn) 25:1712–1731

PubMed  Google Scholar 

Khefli A, Azzouz M, Abtroun R et al (2017) Exploration des myopathies toxiques: de l’anamnèse aux méthodes de pharmacogénomique. Toxicol Analyt Clin 29:273–297

Google Scholar 

Wattjes MP, Fisher DS (2013) Neuromuscular imaging. Springer, New York

Book  Google Scholar 

Hooijmans MT, Schlaffke L, Bolsterlee B et al (2023) Compositional and functional MRI of skeletal muscle: a review. J Magn Reson Imaging. https://doi.org/10.1002/jmri.29091

Article  PubMed  Google Scholar 

Bowden DH, Fraser D, Jackson SH et al (1956) Acute recurrent rhabdomyolysis (paroxysmal myohaemoglobinuria); a report of three cases and a review of the literature. Medicine (Baltimore) 35:335–353

Article  CAS  PubMed  Google Scholar 

Coco TJ, Klasner AE (2004) Drug-induced rhabdomyolysis. Curr Opin Pediatr 16:206–210

Article  PubMed  Google Scholar 

Du Souich P, Roederer G, Dufour R (2017) Myotoxicity of statins: mechanism of action. Pharmacol Ther 175:1–16

Article  PubMed  Google Scholar 

Ho CK, Walker SW (2012) Statins and their interactions with other lipid-modifying medications: safety issues in the elderly. Ther Adv Drug Saf 3:35–46

Article  PubMed  PubMed Central  Google Scholar 

Tournadre A (2020) Statins, myalgia, and rhabdomyolysis. Joint Bone Spine 87:37–42

Article  CAS  PubMed  Google Scholar 

Silva M, Matthews ML, Jarvis C et al (2007) Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Clin Ther 29:253–260

Article  CAS  PubMed  Google Scholar 

Chérin P (2014) Myopathies aux statines. NPG Neurol Psychiatr Geriatr 14:11–16

Google Scholar 

Joy TR, Hegele RA (2009) Narrative review: statin-related myopathy. Ann Intern Med 150:858–868

Article  PubMed  Google Scholar 

Watanabe Y, Uruha A, Suzuki S et al (2016) Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J Neurol Neurosurg Psychiatry 87:1038–1044

Article  PubMed  Google Scholar 

Allenbach Y, Benveniste O, Stenzel W et al (2020) Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol 16:689–701

Article  CAS  PubMed  Google Scholar 

Tiniakou E, Pinal-Fernandez I, Lloyd TE et al (2017) More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase-associated autoimmune myopathy. Rheumatology (Oxford) 56:787–794

CAS  PubMed  Google Scholar 

Wang D, Wang Y (2018) Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: a rare case report and literature review. Medicine (Baltimore) 97:e0318

Article  PubMed  Google Scholar 

Pierce LR, Wysowski DK, Gross TP (1990) Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA 264:71–75

Article  CAS  PubMed  Google Scholar 

Sauvaget F, Piette JC, Herson S et al (1991) Polymyosite induite par le fénofibrate. Rev Med Interne 12:52–54

Article  CAS  PubMed  Google Scholar 

Litin SC, Anderson CF (1989) Nicotinic acid-associated myopathy: a report of three cases. Am J Med 86:481–483

Article  CAS  PubMed  Google Scholar 

Slim H, Thompson PD (2008) Ezetimibe-related myopathy: a systematic review. J Clin Lipidol 2:328–334

Article  PubMed  Google Scholar 

Prasad GV, Wong T, Meliton G et al (2002) Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient. Transplantation 74:1200–1201

Article  PubMed  Google Scholar 

Gürgöze MT, Muller-Hansma AHG, Schreuder MM et al (2019) Adverse events associated with PCSK9 inhibitors: a real-world experience. Clin Pharmacol Ther 105:496–504

Article  PubMed  Google Scholar 

Ding L, Chen C, Yang Y et al (2022) Musculoskeletal adverse events associated with PCSK9 inhibitors: disproportionality analysis of the FDA adverse event reporting system. Cardiovasc Ther 2022:9866486

Article  PubMed  PubMed Central  Google Scholar 

Banach M, Duell PB, Gotto AM Jr et al (2020) Association of bempedoic acid administration with atherogenic lipid levels in phase 3 randomized clinical trials of patients with hypercholesterolemia. JAMA Cardiol 5:1124–1135

Article  PubMed  Google Scholar 

Cushing H (1932) The basophil adenoma of the pituitary body and their clinical manifestation. Johns Hopkins Med J 50:137–195

Google Scholar 

Alshekhlee A, Kaminski HJ, Ruff RL (2002) Neuromuscular manifestations of endocrine disorders. Neurol Clin 20(35–58):v–vi

Google Scholar 

Schakman O, Gilson H, Thissen JP (2008) Mechanisms of glucocorticoid-induced myopathy. J Endocrinol 197:1–10

Article  CAS  PubMed  Google Scholar 

Gupta A, Gupta Y (2013) Glucocorticoid-induced myopathy: pathophysiology, diagnosis, and treatment. Indian J Endocrinol Metab 17:913–916

Article  PubMed  PubMed Central  Google Scholar 

Pereira RM, Freire de Carvalho J (2011) Glucocorticoid-induced myopathy. Joint Bone Spine 78:41–44

Article  CAS  PubMed  Google Scholar 

Hanson P, Dive A, Brucher JM et al (1997) Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 20:1371–1380

Article  CAS  PubMed  Google Scholar 

Janssens S, Decramer M (1989) Corticosteroid-induced myopathy and the respiratory muscles. Report of two cases. Chest 95:1160–1162

Article  CAS  PubMed  Google Scholar 

Decramer M, de Bock V, Dom R (1996) Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153:1958–1964

Article  CAS  PubMed  Google Scholar 

Askari A, Vignos PJ Jr, Moskowitz RW (1976) Steroid myopathy in connective tissue disease. Am J Med 61:485–492

Article  CAS  PubMed  Google Scholar 

Mitsui T, Azuma H, Nagasawa M et al (2002) Chronic corticosteroid administration causes mitochondrial dysfunction in skeletal muscle. J Neurol 249:1004–1009

Article  CAS  PubMed  Google Scholar 

Khaleeli AA, Edwards RH, Gohil K et al (1983) Corticosteroid myopathy: a clinical and pathological study. Clin Endocrinol (Oxf) 18:155–166

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif